课题基金 / 基金详情

Task V02: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates

Task V02: Immunogenicity and Efficacy Testing of Medical Countermeasures (Vaccines and Other Biologics) against BSL-4 Pathogens in Non-Human Primates
任务 V02：针对非人类灵长类动物中 BSL-4 病原体的医疗对策（疫苗和其他生物制品）的免疫原性和功效测试
批准号：
10712849
负责人：
THOMAS RUDGE
金额：
$246.78万
依托单位：
BATTELLE CENTERS/PUB HLTH RES & EVALUATN
依托单位国家：
美国
项目类别：
财政年份：
2019
资助国家：
美国
项目状态：
未结题
起止时间：
2019-08-01 至 2025-12-31
来源：
https://reporter.nih.gov/project-details/10712849
关键词：
BiologicalBiological ProductsCommunicable DiseasesContractsDevelopmentFeasibility StudiesInvestigational New Drug ApplicationLicensingNipah VirusServicesVaccinesefficacy testingevaluation/testingimmunogenicitymedical countermeasurenonhuman primatenovel vaccinespathogenproduct developmenttesting servicesvaccine candidatevaccine development

项目摘要

项目成果

THOMAS RUDGE的其他基金

相似基金

相关文献

中文摘要
翻译
用于传染病的疫苗和其他生物制剂的评估和测试服务（ETS）合同提供各种产品开发服务，从早期可行性研究到提交生物许可证申请（BLA）和/或研究新药（IND）申请所需的活动。这些服务将促进开发和引进新的候选疫苗和生物制剂（由CBER管理），以预防一系列广泛的传染病。
英文摘要
The Evaluation and Testing Services (ETS) for Vaccines and Other Biologics for Infectious Diseases contract provides a variety of product development services from early feasibility studies through activities required for the submission of Biologic License Application (BLA) and/or Investigational New Drug (IND) applications. These services will facilitate the development and introduction of new vaccine candidates and biologics (regulated by CBER) against a wide array of infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task V18: STUDY TO EVALUATE THE EFFICACY OF TOXIN IN ANIMAL MODEL
TASK V17: DEVELOPMENT OF ASSAYS AND REAGENTS FOR MONKEYPOX VACCINES
TASK V13: DEEP ANTIBODY PROFILING FOR INFECTION AND VACCINATION
Task V12: CLINICAL SAMPLE TESTING FOR ZIKA VIRUS VACCINES
海外基金